These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17956262)

  • 1. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.
    Fields AP; Frederick LA; Regala RP
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells.
    Stallings-Mann M; Jamieson L; Regala RP; Weems C; Murray NR; Fields AP
    Cancer Res; 2006 Feb; 66(3):1767-74. PubMed ID: 16452237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase Ciota.
    Erdogan E; Lamark T; Stallings-Mann M; Lee Jamieson ; Pellecchia M; Thompson EA; Johansen T; Fields AP
    J Biol Chem; 2006 Sep; 281(38):28450-9. PubMed ID: 16861740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer.
    Regala RP; Weems C; Jamieson L; Khoor A; Edell ES; Lohse CM; Fields AP
    Cancer Res; 2005 Oct; 65(19):8905-11. PubMed ID: 16204062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway.
    Liu SG; Wang BS; Jiang YY; Zhang TT; Shi ZZ; Yang Y; Yang YL; Wang XC; Lin DC; Zhang Y; Yang H; Cai Y; Zhan QM; Wang MR
    Mol Cancer Res; 2011 Apr; 9(4):390-402. PubMed ID: 21310827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity.
    Regala RP; Weems C; Jamieson L; Copland JA; Thompson EA; Fields AP
    J Biol Chem; 2005 Sep; 280(35):31109-15. PubMed ID: 15994303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.
    Butler AM; Scotti Buzhardt ML; Erdogan E; Li S; Inman KS; Fields AP; Murray NR
    Oncotarget; 2015 Jun; 6(17):15297-310. PubMed ID: 25915428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling.
    Baldwin RM; Garratt-Lalonde M; Parolin DA; Krzyzanowski PM; Andrade MA; Lorimer IA
    Oncogene; 2006 May; 25(20):2909-19. PubMed ID: 16331246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical protein kinase Cι as a human oncogene and therapeutic target.
    Parker PJ; Justilien V; Riou P; Linch M; Fields AP
    Biochem Pharmacol; 2014 Mar; 88(1):1-11. PubMed ID: 24231509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
    Murray NR; Kalari KR; Fields AP
    J Cell Physiol; 2011 Apr; 226(4):879-87. PubMed ID: 20945390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of the human full-length protein kinase Ciota.
    Macek B; Benda C; Jestel A; Maskos K; Mann M; Messerschmidt A
    J Proteome Res; 2008 Jul; 7(7):2928-35. PubMed ID: 18489133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent copy number gains drive PKCι expression and PKCι-dependent oncogenic signaling in human cancers.
    Liu Y; Justilien V; Fields AP; Murray NR
    Adv Biol Regul; 2020 Dec; 78():100754. PubMed ID: 32992230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure of atypical protein kinase C PB1 domain and its mode of interaction with ZIP/p62 and MEK5.
    Hirano Y; Yoshinaga S; Ogura K; Yokochi M; Noda Y; Sumimoto H; Inagaki F
    J Biol Chem; 2004 Jul; 279(30):31883-90. PubMed ID: 15143057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncogenic role of PKCiota gene amplification and overexpression in Chinese non-small cell lung cancer.
    Luo Q; Tang L; Lin H; Huang J; Zhang T; Liu Y; Wang J; Zhan P; Yin X; Su X; Ji Q; Yu D; Xu L
    Lung Cancer; 2014 May; 84(2):190-5. PubMed ID: 24636699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT; Leder P
    Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma.
    Zhang L; Huang J; Yang N; Liang S; Barchetti A; Giannakakis A; Cadungog MG; O'Brien-Jenkins A; Massobrio M; Roby KF; Katsaros D; Gimotty P; Butzow R; Weber BL; Coukos G
    Cancer Res; 2006 May; 66(9):4627-35. PubMed ID: 16651413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis.
    Scotti ML; Bamlet WR; Smyrk TC; Fields AP; Murray NR
    Cancer Res; 2010 Mar; 70(5):2064-74. PubMed ID: 20179210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKCι maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesis.
    Wang Y; Hill KS; Fields AP
    Mol Cancer Res; 2013 Dec; 11(12):1624-35. PubMed ID: 24174471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer.
    Frederick LA; Matthews JA; Jamieson L; Justilien V; Thompson EA; Radisky DC; Fields AP
    Oncogene; 2008 Aug; 27(35):4841-53. PubMed ID: 18427549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.